Results 271 to 280 of about 4,938,261 (300)

OCULAR MANIFESTATIONS OF PRIMARY MYELOFIBROSIS

RETINAL Cases & Brief Reports, 2016
Purpose: To report ocular manifestations of idiopathic primary myelofibrosis in a patient with relapsed primary myelofibrosis. Methods: Observational case report. Results: A 57-year-old African American male with history of primary ...
Albert L, Lin, Jordan M, Burnham, Victor, Pang, Omolola, Idowu, Siva, Iyer   +4 more
openaire   +2 more sources

An unusual presentation of primary myelofibrosis

Indian Journal of Tuberculosis, 2018
Extramedullary hematopoisis (EMH) normally occurs in fetal life, but it is pathological in later life and most of the time because of underlying marrow diseases. Sometimes EMH tissue can present with large masses which can cause compressive and constitutional symptoms. They can be wrongly diagnosed as malignancy and pulmonary tuberculosis. Here in this
Prateek, Tiwari, Vandana, Mahajan, Kanchan, Muhrerkar   +2 more
openaire   +2 more sources

Ruxolitinib for the treatment of primary myelofibrosis

American Journal of Health-System Pharmacy, 2014
The pharmacology, pharmacokinetics, pharmacogenomics, clinical efficacy, and safety profile of ruxolitinib for the treatment of primary myelofibrosis are reviewed.Ruxolitinib, an oral tyrosine kinase inhibitor that targets the Janus-associated kinases (JAKs) 1 and 2, has been recently approved for the treatment of patients with intermediate- or high ...
openaire   +2 more sources

Primary Myelofibrosis In Children

Blood, 2010
Abstract Abstract 3079 Primary myelofibrosis is a chronic myeloproliferative disorder characterized by cytopenias, leukoerythroblastosis, extramedullary hematopoiesis, hepatosplenomegaly and bone marrow fibrosis. It is a serious medical condition in adults, often requiring major interventions such as hematopoietic stem ...
Melissa R. DeLario, Andrea Sheehan, Ramona Ataya, Alison A. Bertuch, Carlos Vega, C. Renee Webb, Dolores lopez-Terrada, Lakshmi Venkateswaran   +7 more
openaire   +1 more source

Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis

Wiener Klinische Wochenschrift, 2021
M. Lucijanić, I. Krečak, D. Galušić, M. Sedinić, H. Holik, V. Periša, M. Morić Perić, I. Zekanović, T. Štoos‐Veič, V. Pejsa, R. Kušec   +10 more
semanticscholar   +1 more source

Distinguishing autoimmune myelofibrosis from primary myelofibrosis.

Clinical advances in hematology & oncology : H&O, 2018
Bone marrow fibrosis (BMF) is a histologic finding in a wide range of diseases, including malignancies, endocrine disorders, autoimmune diseases, and infections. Autoimmune myelofibrosis (AIMF) is an uncommon etiology of BMF; it can be secondary to a defined autoimmune disease, or it can be primary in the absence of a clinically diagnosed autoimmune ...
Bridget, Marcellino, Siraj M, El Jamal, John O, Mascarenhas   +2 more
openaire   +1 more source

Treatment considerations for primary myelofibrosis.

The Netherlands journal of medicine, 2010
No abstract ...
openaire   +2 more sources

ABOUT PRIMARY MYELOFIBROSIS:

European Journal of Haematology, 1988
openaire   +2 more sources

Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature

Clinical and Experimental Medicine (Testo stampato), 2020
G. Coltro, F. Mannelli, F. Vergoni, R. Santi, D. Massi, L. Siliani, A. Marzullo, S. Bonifacio, E. Pelo, Annalisa Pacilli, C. Paoli, A. Franci, L. Calabresi, A. Bosi, A. Vannucchi, P. Guglielmelli   +15 more
semanticscholar   +1 more source

A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.

Blood reviews, 2020
Benjamin Garmezy, J. Schaefer, Jessica Mercer, M. Talpaz   +3 more
semanticscholar   +1 more source